![Yasuo Fujii](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yasuo Fujii
Director/Board Member at ORCHARD THERAPEUTICS PLC
Yasuo Fujii active positions
Companies | Position | Start | End |
---|---|---|---|
KYOWA KIRIN CO. LTD. | Corporate Officer/Principal | 01/04/1988 | - |
ORCHARD THERAPEUTICS PLC | Director/Board Member | 24/01/2024 | - |
Career history of Yasuo Fujii
Former positions of Yasuo Fujii
Companies | Position | Start | End |
---|---|---|---|
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Corporate Officer/Principal | 01/09/2012 | - |
Training of Yasuo Fujii
University of Illinois | Masters Business Admin |
Statistics
International
United Kingdom | 3 |
Japan | 2 |
United States | 2 |
Operational
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
KYOWA KIRIN CO. LTD. | Health Technology |
Private companies | 2 |
---|---|
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
Orchard Therapeutics Plc
![]() Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Yasuo Fujii
- Experience